A novel UBE3A truncating mutation in large Tunisian Angelman syndrome pedigree. 2010

L Abaied, and M Trabelsi, and M Chaabouni, and M Kharrat, and L Kraoua, and R M'rad, and N Tebib, and F Maazoul, and H Chaabouni
Faculté de Médecine de Tunis, Laboratoire de Génétique Humaine, Tunis, Tunisia.

We identified in a large Tunisian pedigree a novel UBE3A frameshift mutation in exon 16 coding region, and we expect that the resulting UBE3A truncated protein in our patients is non-functional since the mutation implies the catalytic region of the enzyme. The family includes 14 affected patients born from four sisters. This mutation was found in all surviving affected individuals and their mothers pointing out the importance of genetic counseling possibility in Angelman syndrome (AS). All patients had severe mental retardation with epilepsy and microcephaly. Minor clinical expression variation was observed among the investigated patients. The severity of clinical expression is related to the detected molecular variation: deletion of 15 bp and insertion of 7 bp. These results are concordant with the gene expression observed in previously reported individuals with AS and truncated UBE3A protein.

UI MeSH Term Description Entries
D008297 Male Males
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D014416 Tunisia A country in northern Africa between ALGERIA and LIBYA. Its capital is Tunis.
D017204 Angelman Syndrome A syndrome characterized by multiple abnormalities, MENTAL RETARDATION, and movement disorders. Present usually are skull and other abnormalities, frequent infantile spasms (SPASMS, INFANTILE); easily provoked and prolonged paroxysms of laughter (hence "happy"); jerky puppetlike movements (hence "puppet"); continuous tongue protrusion; motor retardation; ATAXIA; MUSCLE HYPOTONIA; and a peculiar facies. It is associated with maternal deletions of chromosome 15q11-13 and other genetic abnormalities. (From Am J Med Genet 1998 Dec 4;80(4):385-90; Hum Mol Genet 1999 Jan;8(1):129-35) Happy Puppet Syndrome,Puppet Children,Children, Puppet,Syndrome, Angelman,Syndrome, Happy Puppet
D044767 Ubiquitin-Protein Ligases A diverse class of enzymes that interact with UBIQUITIN-CONJUGATING ENZYMES and ubiquitination-specific protein substrates. Each member of this enzyme group has its own distinct specificity for a substrate and ubiquitin-conjugating enzyme. Ubiquitin-protein ligases exist as both monomeric proteins multiprotein complexes. Ubiquitin-Protein Ligase,E3 Ligase,E3 Ubiquitin Ligase,Ubiquitin Ligase E3,Ubiquitin-Protein Ligase E3,Ligase E3, Ubiquitin,Ligase E3, Ubiquitin-Protein,Ligase, E3,Ligase, E3 Ubiquitin,Ligase, Ubiquitin-Protein,Ligases, Ubiquitin-Protein,Ubiquitin Ligase, E3,Ubiquitin Protein Ligase,Ubiquitin Protein Ligase E3,Ubiquitin Protein Ligases

Related Publications

L Abaied, and M Trabelsi, and M Chaabouni, and M Kharrat, and L Kraoua, and R M'rad, and N Tebib, and F Maazoul, and H Chaabouni
October 2005, American journal of medical genetics. Part A,
L Abaied, and M Trabelsi, and M Chaabouni, and M Kharrat, and L Kraoua, and R M'rad, and N Tebib, and F Maazoul, and H Chaabouni
May 2018, Indian journal of pediatrics,
L Abaied, and M Trabelsi, and M Chaabouni, and M Kharrat, and L Kraoua, and R M'rad, and N Tebib, and F Maazoul, and H Chaabouni
August 2008, Journal of child neurology,
L Abaied, and M Trabelsi, and M Chaabouni, and M Kharrat, and L Kraoua, and R M'rad, and N Tebib, and F Maazoul, and H Chaabouni
December 2014, Human mutation,
L Abaied, and M Trabelsi, and M Chaabouni, and M Kharrat, and L Kraoua, and R M'rad, and N Tebib, and F Maazoul, and H Chaabouni
June 1998, American journal of human genetics,
L Abaied, and M Trabelsi, and M Chaabouni, and M Kharrat, and L Kraoua, and R M'rad, and N Tebib, and F Maazoul, and H Chaabouni
January 1997, Nature genetics,
L Abaied, and M Trabelsi, and M Chaabouni, and M Kharrat, and L Kraoua, and R M'rad, and N Tebib, and F Maazoul, and H Chaabouni
March 2013, Journal of child neurology,
L Abaied, and M Trabelsi, and M Chaabouni, and M Kharrat, and L Kraoua, and R M'rad, and N Tebib, and F Maazoul, and H Chaabouni
December 2012, BMC medical genetics,
L Abaied, and M Trabelsi, and M Chaabouni, and M Kharrat, and L Kraoua, and R M'rad, and N Tebib, and F Maazoul, and H Chaabouni
June 2022, Biomedical reports,
L Abaied, and M Trabelsi, and M Chaabouni, and M Kharrat, and L Kraoua, and R M'rad, and N Tebib, and F Maazoul, and H Chaabouni
August 2009, Human genetics,
Copied contents to your clipboard!